Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Bismutsubcitrat, Tetracyclin und Metronidazol, ATC A02BD08

Conclusion of non-exclusive rebate contracts in accordance with §§ 130a (8)/130c (1) SGB V for medicinal products with the aforementioned active substance within the period from 01.07.2026 to 30.06.2028 with the possibility of concluding the contract at any time (open-house model). In the open-house procedure, medicinal products according to the BfArM list under § 35 (5a) SGB V (paediatric medicinal products) are excluded.